| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4268896 | European Urology Focus | 2016 | 7 Pages |
Abstract
Among activated VHL tumors, the wild-type subgroup defines an aggressive phenotype with worse survival rates, suggesting that these tumors must be more thoroughly screened.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Julien Dagher, Solène-Florence Kammerer-Jacquet, Angélique Brunot, Adélaide Pladys, Jean-Jacques Patard, Karim Bensalah, Christophe Perrin, Grégory Verhoest, Jean Mosser, Alexandra Lespagnol, Cécile Vigneau, Frédéric Dugay,